Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-12-14 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock Option (right to Buy) +275,000 275,000
2021-09-03 MANNINO RAPHAEL J Chief Scientific Officer Other acquisition +462,150 1,919,715
2021-06-19 MANNINO RAPHAEL J Chief Scientific Officer Other acquisition +8,000 1,437,565
2021-06-19 MANNINO RAPHAEL J Chief Scientific Officer Conversion +20,000 1,457,565
2021-06-19 MANNINO RAPHAEL J Chief Scientific Officer Conversion · Series B Preferred Stock −10 0
2021-01-01 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock option (right to buy) +200,000 200,000
2020-06-23 MANNINO RAPHAEL J Chief Scientific Officer Other acquisition +3,000 1,429,565
2020-06-17 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock option (right to buy) +50,000 50,000
2020-01-01 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock option (right to buy) +100,000 100,000
2019-06-21 MANNINO RAPHAEL J Chief Scientific Officer Other acquisition +2,000 1,426,565
2019-02-11 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock option (right to buy) +150,000 150,000
2018-06-21 MANNINO RAPHAEL J Chief Scientific Officer Purchase · Series B Convertible Preferred Stock +10 $1,000.00 $10K 10
2018-04-30 MANNINO RAPHAEL J Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2017-09-11 MANNINO RAPHAEL J Chief Scientific Officer Purchase +5,000 $1.41 $7K 1,424,565

Page 1 of 1 · 14 trades